CD4 and Alzheimer disease: TSLP can also directly act on circulating CD4+ T cells in AD patients, which show increased expression of the TSLPR compared with healthy subjects; the frequency of circulating TSLPR + CD4 + T cells correlates with serum CCL17/TARC and IgE levels and eosinophil counts [403].